Abstract
Purpose
To analyze the features of optic nerve head drusen (ONHD) observed on the optical coherence tomography (OCT) of pediatric and adolescent patients and to compare the characteristics of diagnosed ONHD pediatric and adolescent patients with the control group.
Methods
We performed a retrospective chart review of pediatric and adolescent patients with nasal elevation or marginal blur-ring of the optic nerve head on either direct ophthalmoscopic examination or fundus photography. Patients were compared with a control group of the same age who had normal optic nerve heads and no abnormal findings except refractive errors under oph-thalmic examination including OCT.
Results
There were 29 eyes (n = 16) with ONHD as a subretinal mass-like lesion on OCT among 84 eyes with nasal elevation or marginal blurring of the optic nerve head on OCT. Thirteen patients (18.8%) were diagnosed with ONHD in both eyes. The fol-lowing 3 groups were compared: group 1, showing nasal elevation or marginal blurring of the optic nerve head on OCT and diag-nosed with ONHD; group 2, without ONHD; group 3, normal controls. The spherical equivalent was significantly different among the groups ( p < 0.001). Compared with group 3, group 1 showed peripapillary retinal nerve fiber layer thickening of the temporal area; however, there was no difference between groups 1 and 2.
References
1. Boyce SW, Platia EV, Green WR. Drusen of the optic nerve head. Ann Ophthalmol. 1978; 10:695–704.
3. Tso MO. Pathology and pathogenesis of drusen of the optic nervehead. Ophthalmology. 1981; 88:1066–80.
4. Lee CK. Optic nerve drusen. J Korean Ophthalmol Soc. 1983; 24:175–90.
5. Erkkilä H. Optic disc drusen in children. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1973; 189:1–7.
6. Erkkilä H. Clinical appearance of optic disc drusen in childhood. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1975; 193:1–18.
7. Kurz-Levin MM, Landau K. A comparison of imaging techniques for diagnosing drusen of the optic nerve head. Arch Ophthalmol. 1999; 117:1045–9.
8. Lee KM, Woo SJ, Hwang JM. Differentiation of optic nerve head drusen and optic disc edema with spectral-domain optical coher-ence tomography. Ophthalmology. 2011; 118:971–7.
9. Johnson LN, Diehl ML, Hamm CW. . Differentiating optic disc edema from optic nerve head drusen on optical coherence tomography. Arch Ophthalmol. 2009; 127:45–9.
10. Kang SH, Hong SW, Im SK. . Effect of myopia on the thick-ness of the retinal nerve fiber layer measured by Cirrus HD optical coherence tomography. Invest Ophthalmology Vis Sci. 2010; 51:4075–83.
11. Jonas JB, Gusek GC, Guggenmoos-Holzmann I, Naumann GO. Optic nerve head drusen associated with abnormally small optic discs. Int Ophthalmol. 1987; 11:79–82.
12. Mullie MA, Sanders MD. Scleral canal size and optic nerve head drusen. Am J Ophthalmol. 1985; 99:356–9.
13. Sacks JG, O'Grady RB, Choromokos E, Leestma J. The patho-genesis of optic nerve drusen. A hypothesis. Arch Ophthalmol. 1977; 95:425–8.
14. Giuffré G. Optic disc drusen in tilted disc. Eur J Ophthalmol. 2005; 15:647–51.
15. Vongphanit J, Mitchell P, Wang JJ. Population prevalence of tilted optic disks and the relationship of this sign to refractive error. Am J Ophthalmol. 2002; 133:679–85.
16. Carta A, Favilla S, Prato M. . Accuracy of funduscopy to iden-tify true edema versus pseudoedema of the optic disc. Invest Ophthalmol Vis Sci. 2012; 53:1–6.
18. Merchant KY, Su D, Park SC. . Enhanced depth imaging optical coherence tomography of optic nerve head drusen. Ophthalmology. 2013; 120:1409–14.
19. Kim TW, Kim M, Weinreb RN. . Optic disc change with in-cipient myopia of childhood. Ophthalmology. 2012; 119:21–6.e1-3.
20. Hwang YH, Yoo C, Kim YY. Characteristics of peripapillary reti-nal nerve fiber layer thickness in eyes with myopic optic disc tilt and rotation. J Glaucoma. 2012; 21:394–400.
21. Hwang YH, Yoo C, Kim YY. Myopic optic disc tilt and the charac-teristics of peripapillary retinal nerve fiber layer thickness meas-ured by spectral-domain optical coherence tomography. J Glaucoma. 2012; 21:260–5.
22. Lorentzen SE. Drusen of the optic disk. A clinical and genetic study. Acta Ophthalmol (Copenh). 1966; Suppl 90. 1–180.
23. Pietruschka G, Priess G. Clinical importance and prognosis of dru-sen of the disc. Klin Monbl Augenheilkd. 1973; 162:331–41.
24. Romero J, Sowka J, Shechtman D. Hemorrhagic complications of optic disc drusen and available treatment options. Optometry. 2008; 79:496–500.
25. Harris MJ, Fine SL, Owens SL. Hemorrhagic complications of op-tic nerve drusen. Am J Ophthalmol. 1981; 92:70–6.
26. Choi WG, Jang JH. A case of optic disc hemorrhage associated with buried optic disc nerve head drusen. J Korean Ophthalmol Soc. 2014; 55:1099–105.
27. Katz BJ, Pomeranz HD. Visual field defects and retinal nerve fiber layer defects in eyes with buried optic nerve drusen. Am J Ophthalmol. 2006; 141:248–53.
28. Erkkilä H. Optic disc drusen in children. Acta Ophthalmol Suppl. 1977; ((129)):3–44.
29. Komur M, Sari A, Okuyaz C. Simultaneous papilledema and optic disc drusen in a child. Pediatr Neurol. 2012; 46:187–8.
30. Seo du R, Park SH. Case of rapidly progressing buried optic nerve head drusen. JAMA Ophthalmol. 2015; 133:e143467.
31. Piccone MR, Piltz-Seymour JR, Shin D. Coexisting optic nerve head drusen and glaucoma. Ophthalmology. 1998; 105:761–2.
32. Chaudhry NA, Lavaque AJ, Shah A, Liggett PE. Photodynamic therapy for choroidal neovascular membrane secondary to optic nerve drusen. Ophthalmic Surg Lasers Imaging. 2005; 36:70–2.
33. Silva R, Torrent T, Loureiro R. . Bilateral CNV associated with optic nerve drusen treated with photodynamic therapy with verteporfin. Eur J Ophthalmol. 2004; 14:434–7.
Table 1.
Table 2.
Group 1∗ (n = 29) | Group 2† (n = 23) | Group 3‡ (n = 33) | p-value | |
---|---|---|---|---|
Age (average) | 10.24 ± 2.4 | 9.52 ± 1.93 | 9.43 ± 2.55 | 0.091§ |
Male:female | 17:12 | 5:18 | 21:12 | 0.005∏ |
BCVA (log MAR) | 0.01 ± 0.03 | 0.00 | 0.00 | 0.132§ |
Spherical equivalent (D) | -3.61 ± 1.69 | -1.77 ± 2.14 | -0.17 ± 1.47 | <0.001§ |
Cylinder power (D) | -0.88 ± 0.92 | -0.32 ± 0.52 | -0.82 ± 1.08 | 0.054§ |
Table 3.
Nasal | Superonasal | Superotemporal | Temporal | Inferotemporal | Inferonasal | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
β p-value§(95% CI, μ m) | β p-value§(95% CI, μ m) | β p-value§(95% CI, μ m) | β p-value§(95% CI, μ m) | β p-value§(95% CI, μ m) | β (95% CI, μ m) p-value§ | |||||||
Group 1∗ Reference (n = 29) | Reference | Reference | Reference | Reference | Reference | |||||||
Group 2†(n = 23) | -2.87 | 0.555 | -14.46 | 0.103 | -7.84 | 0.278 | -8.69 | 0.131 | -14.48 | 0.076 | 3.53 | 0.584 |
(n = 23) | (-12.52~6.77) | (-31.92~2.98) | (-22.11~6.43) | (-20.02~2.65) | (-30.54~1.57) | (-30.54~1.57) | (-9.25~16.30) | |||||
1.82 | 0.772 | 2.69 | 0.772 | 1.772 | 1.17 | 0.877 | ||||||
Group 3‡ | 1.82 | 2.69 | 0.772 | 1.17 | 0.877 | -20.83 | 0.001 | -21.98 | 0.012 | 9.07 | 0.184 | |
(n=33) | (-8.35~11.99) | (-15.71~21.09) | (-13.88~-16.22) | (-32.78~-8.87) | (-38.91~-5.05) | (-4.40~22.54) |